Transgenic models of growth hormone action

Annual Review of Nutrition

Volumn 19, Issue , 1999, Pages 437-461

  Kopchick, John J ^a,b   Bellush, Linda L ^a   Coschigano, Karen T ^a  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Anti insulin activity; Insulin like growth factor I; Metabolism; Microinjection; Nutrition

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL MODEL; GROWTH HORMONE RELEASE; HORMONE ACTION; HYPOPHYSIS; MEDICAL RESEARCH; MOUSE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; GROWTH HORMONE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 0032802960     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.19.1.437     Document Type: Review

References (163)

1. 1. Abdel-Meguid SS, Shieh HS, Smith WW, Dayringer HE, Violand BN, Bentle LA. 1987. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl. Acad. Sci. USA 84:6434-37
2. 2. Altszuler N, Steele R, Rathgeb I, de Bodo RC. 1967. Glucose metabolism and plasma insulin level during epinephrine infusion in the dog. Am. J. Physiol. 212: 677-82
3. 3. Altszuler N, Steele R, Rathgeb I, de Bodo RC. 1968. Influence of growth hormone on glucose metabolism and plasma insulin levels in the dog. In Growth Hormone, ed. A Pecile, EE Muller, pp. 309-315. Amsterdam: Excerpta Med. Int. Congr. Ser. 158
4. 4. Alzaid AA, Dinneen SF, Melton LJ III, Rizza RA. 1994. The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 17:531-34
5. 5. Anderson NG. 1992. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem. J. 284:649-52
6. 6. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, et al. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-44
7. 7. Argetsinger LS, Carter-Su C. 1996. Mechanism of signaling by growth hormone receptor. Physiol. Rev. 76:1089-107
8. 8. Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. 1995. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:14685-92
9. 9. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. 1996. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J. Biol. Chem. 271:29415-21
10. 10. Batchelor BR, Mahler RJ. 1972. Growth hormone-induced enhancement of insulin sensitivity in adipose tissue. Horm. Metab. Res. 4:87-92
11. 11. Baumann G. 1990. Growth hormone binding proteins and various forms of growth hormone: implications for measurements. Acta Paediatr. Scand. Suppl. 370:72-80
12. 12. Baumann G. 1991. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr. Rev. 12:424-49
13. 13. Bellush LL, Holland AN, Kopchick JJ. 1998. Altered glucose tolerance in transgenic mice expressing a bovine growth hormone antagonist. Endocr. Soc. 80:143 (Abstr.)
14. 14. Bergad PL, Shih HM, Towle HC, Schwarzenberg SJ, Berry SA. 1995. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J. Biol. Chem. 270:24903-10
15. 15. Billestrup N, Bouchelouche P, Allevato G, Ilondo M, Nielsen JH. 1995. Growth hormone receptor C-terminal domains required for growth hormone-induced intracellular free Ca2+ oscillations and gene transcription. Proc. Natl. Acad. Sci. USA 92:2725-29
16. 16. Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM. 1989. Transgenic mice with inducible dwarfism. Nature 339:538-41
17. 17. Brogan RS, Fife SK, Conley LK, Giustina A, Wehrenberg WB. 1997. Effects of food deprivation on the GH axis: immunocytochemical and molecular analysis. Neuroendocrinology 65:129-35
18. 18. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C. 1995. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J. Biol. Chem. 270: 3974-79
19. 19. Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter-Su C. 1992. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J. Biol. Chem. 267:6074-80
20. 20. Casanueva FF. 1992. Physiology of growth hormone secretion and action. Endocrinol Metab. Clin. N. Am. 21:483-517
21. 21. Cataldo LA, Kopchick JJ. 1998. Characterization of growth hormone mediated signal transduction in mouse liver. Endocr. Soc. 80:143 (Abstr.)
22. 22. Catalioto RM, Ailhaud G, Negrel R. 1990. Diacylglycerol production induced by growth hormone in Ob1771 preadipocytes arises from phosphatidylcholine breakdown. Biochem. Biophys. Res. Commun. 173:840-48
23. 23. Cecim M, Fadden C, Kerr J, Steger RW, Bartke A. 1995. Infertility in transgenic mice overexpressing the bovine growth hormone gene: disruption of the neuroendocrine control of prolactin secretion during pregnancy. Biol. Reprod. 52:1187-92
24. 24. Cecim M, Kerr J, Bartke A. 1995. Effects of bovine growth hormone (bGH) transgene expression or bGH treatment on reproductive functions in female mice. Biol. Reprod. 52:1144-48
25. 25. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell Biol. 14:4902-11
26. 26. Chen C, Clarkson RW, Xie Y, Hume DA, Waters MJ. 1995. Growth hormone and colony-stimulating factor 1 share multiple response elements in the c-fos promoter. Endocrinology 136:4505-16
27. 27. Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, et al. 1995. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 136:660-67
28. 28. Chen NY, Chen WY, Kopchick JJ. 1996. A growth hormone antagonist protects mice against streptozotocin induced glomerulosclerosis even in the presence of elevated levels of glucose and glycated hemoglobin. Endocrinology 137:5163-65
29. 29. Chen NY, Chen WY, Kopchick JJ. 1997. Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice. Endocrinology 138:1988-94
30. 30. Chen WY, Chen N, Yun J, Wagner TE, Kopchick JJ. 1994. In vitro and in vivo studies of the antagonistic effects of human growth hormone analogs. J. Biol. Chem. 269:15892-97
31. 31. Chen WY, Chen NY, Yun J, Wight DC, Wang XZ, et al. 1995. Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity. Mol. Endocrinol. 9:292-302
32. 32. Chen WY, White ME, Wagner TE, Kopchick JJ. 1991. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129:1402-08
33. 33. Chen WY, Wight DC, Chen NY, Coleman TA, Wagner TE, Kopchick JJ. 1991. Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice. J. Biol. Chem. 266:2252-58
34. 34. Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ. 1991. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol. Endocrinol. 5:1845-52
35. 35. Chen WY, Wight DC, Wagner TE, Kopchick JJ. 1990. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice. Proc. Natl. Acad. Sci. USA 87:5061-65
36. 36. Chen XZ, Shafer AW, Yun JS, Li YS, Wagner TE, Kopchick JJ. 1992. Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rales in transgenic mice. Mol. Endocrinol. 6:598-606
37. 37. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, et al. 1996. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137:2880-86
38. 38. Christiansen JS, Jorgensen JO. 1991. Beneficial effects of GH replacement therapy in adults. Acta Endocrinol. Copenh. 125:7-13
39. 39. Coschigano KT, Bellush LL, Kopchick JJ. 1998. Analysis of a mouse model for Laron syndrome. Endocr. Soc. 80:302 (Abstr.)
40. 40. Cunningham BC, Jhurani P, Ng P, Wells JA. 1989. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 243:1330-36
41. 41. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-25
42. 42. Davidson MB. 1987. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev. 8:115-31
43. 43. de Bodo R, Altszuler N. 1957. The metabolic effects of growth hormone and their physiological significance. Vitam. Horm. 15:206-11
44. 44. de Boer H, Blok GJ, Voerman B, de Vries P, Popp-Snijders C, van der Veen E. 1995. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J. Clin. Endocrinol. Metab. 80:2069-76
45. 45. de Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-12
46. 46. Dinerstein H, Lago F, Goujon L, Ferrag F, Esposito N, et al. 1995. The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription. Mol. Endocrinol. 9:1701-7
47. 47. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, et al. 1988. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am. J. Pathol. 131:398-403
48. 48. Eriksson H, Ridderstrale M, Tornqvist H. 1995. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. Endocrinology 136:5093-101
49. 49. Fain JN, Kovacev VP, Scow RO. 1965. Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J. Biol. Chem. 240:3522-29
50. 50. Frank SJ, Gilliland G, Kraft AS, Arnold CS. 1994. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135:2228-39
51. 51. Fraser R, Joplin JF, Opic M, Rawbinowitz D. 1962. The augmented insulin tolerance test for detecting insulin resistance. J. Endocrinol. 25:299-303
52. 52. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. 1992. Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-80
53. 53. Gaur S, Yamaguchi H, Goodman HM. 1996. Growth hormone increases calcium uptake in rat fat cells by a mechanism dependent on protein kinase C. Am. J. Physiol. 270:C1485-92
54. 54. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, et al. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951-62
55. 55. Gong TW, Meyer DJ, Liao J, Hodge CL, Campbell GS, et al. 1998. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors. Endocrinology 139:1863-71
56. 56. Goodman HM. 1978. The effects of growth hormone on the utilization of L-leucine in adipose tissue. Endocrinology 102:210-17
57. 57. Goodman HM. 1993. Growth hormone and metabolism. In The Endocrinology of Growth, Development, and Metabolism in Vertebrates, ed. MP Schreibman, CG Scanes, PT Pang, pp. 93-115. San Diego: Academic
58. 58. Goodman HM, Grichting G. 1983. Growth hormone and lipolysis: a reevaluation. Endocrinology 113:1697-702
59. 59. Goodman HM, Grichting G. 1986. Growth hormone action on adipocytes. In Human Growth Hormone, ed. S Raiti, RH Tolman, pp. 499-512. New York: Plenum
60. 60. Goodman HM, Schwartz J. 1974. Growth hormone and lipid metabolism. In Cold Spring Harbor Symposium, ed. E Knobil, WH Sawyer, pp. 211-232. Washington, DC: Am. Physiol. Soc.
61. 61. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, et al. 1995. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14:2005-13
62. 62. Greenspan FS, Li CH, Simpson ME, Evans HM. 1949. Bioassay of hypophyseal growth hormone: the tibia test. Endocrinology 45:455-463
63. 63. Gronowski AM, Rotwein P. 1994. Rapid changes in nuclear protein tyrosine phosphorylation after growth hormone treatment in vivo. Identification of phosphorylated mitogen-activated protein kinase and STAT91. J. Biol. Chem. 269:7874-78
64. 64. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell JE Jr, Rotwein P. 1995. In vivo growth hormone treatment rapidly stimulates the tyrosinc phosphorylation and activation of Stat3. Mol. Endocrinol 9:171-77
65. 65. Gurland G, Ashcom G, Cochran BH, Schwartz J. 1990. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes. Endocrinology 127:3187-95
66. 66. Hammer RE, Brinster RL, Palmiter RD. 1986. Use of gene transfer to increase animal growth. In Cold Spring Harbor Symposium. pp. 379-387. Plainview/Cold Spring Harbor, NY: Cold Spring Harbor Lab.
67. 67. Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE. 1985. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-16
68. 68. Harding PA, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ. 1996. Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J. Biol. Chem. 271:6708-12
69. 69. Harding PA, Wang XZ, Kopchick JJ. 1995. Growth hormone (GH)-induced tyrosine-phosphorylated proteins in cells that express GH receptors. Receptor 5: 81-92
70. 70. Hill CS, Treisman R. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211
71. 71. Hjalmarson A, Ahren K. 1967. Sensitivity of the rat diaphragm to growth hormone. II. Early and late effects of growth hormone on amino acid and pentose uptake. Acta Endocrinol. Copenh. 56:347-58
72. 72. Hollobaugh SL, Tzagournis M, Folk RL, Kruger FA, Hamwi GJ. 1968. The diabetogenic action of human growth hormone: glucose-fatty acid interrelationships. Metabolism 17:485-91
73. 73. Hurley DL, Phelps CJ. 1992. Hypothalamic preprosomatostatin messenger ribonucleic acid expression in mice transgenic for excess or deficient endogenous growth hormone. Endocrinology 130:1809-15
74. 74. Ihle JN, Willhuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, et al. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:222-27
75. 75. Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, et al. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-53
76. 76. Kaplan SL, Grumbach MM. 1962. Electrophoretic and immunological characteristics of native and purified human growth hormone. Nature 196:336-38
77. 77. Kineman RD, Aleppo G, Frohman LA. 1996. The tyrosine hydroxylase-human growth hormone (GH) transgenic mouse as a model of hypothalamic GH deficiency: growth retardation is the result of a selective reduction in somatotrope numbers despite normal somatotrope function. Endocrinology 137:4630-36
78. 78. Knapp JR, Chen WY, Turner ND, Byers FM, Kopchick JJ. 1994. Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. J. Anim. Sci. 72:2812-19
79. 79. Kopchick JJ, McAndrew SJ, Shafer A, Blue WT, Yun JS, et al. 1990. In-vitro mutagenesis of the bovine growth hormone gene. J. Reprod. Fertil. Suppl. 41:25-35
80. 80. Kopchick JJ, Woodley FW. 1997. Regulation of growth hormone gene expression. In Advances in Molecular and Cellular Endocrinology, pp. 51-82. Greenwich, CT: JAI
81. 81. Kostyo JL. 1974. The search for the active core of pituitary growth hormone. Metabolism 23:885-99
82. 82. Kostyo JL, Nutting DF. 1973. Acute in vivo effects of growth hormone on protein synthesis in various tissues of hypophysectomized rats and their relationship to the levels of thymidine factor and insulin in the plasma. Horm. Metab. Res. 5:167-72
83. 83. Kovacs M, Kineman RD, Schally AV, Zarandi M, Groot K, Frohman LA. 1997. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology 138:4536-42
84. 84. Lewis UJ, Brink NC. 1958. Crystalline human growth hormone. J. Am. Chem. Soc. 80:4429-30
85. 85. Lewis UJ, Dunn JT, Bonewald LF, Seavey BK, Vanderlaan WP. 1978. A naturally occurring structural variant of human growth hormone. J. Biol. Chem. 253: 2679-87
86. 86. Li CH. 1975. The chemistry of human pituitary growth hormone: 1967-1973. In Hormonal Proteins and Peptides, ed. CH Li, pp. 1-33. New York: Academic
87. 2-terminal amino acid sequence. Arch. Biochem. Biophys. Suppl. 1:327-32
88. 88. MacGorman LR, Rizza RA, Gerich JE. 1981. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J. Clin. Endocrinol. Metab. 53:556-59
89. 89. Maloff BL, Levine JH, Lockwood DH. 1980. Direct effects of growth hormone on insulin action in rat adipose tissue maintained in vitro. Endocrinology 107:538-44
90. 90. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, et al. 1988. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123:2827-33
91. 91. McGrane MM, de Vente J, Yun J, Bloom J, Park E, et al. 1988. Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 263:11443-51
92. 92. McGrane MM, Yun JS, Moorman AF, Lamers WH, Hendrick GK, et al. 1990. Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 265:22371-79
93. 93. Mellado M, Rodriguez-Frade JM, Krenier L, von Kobbe C, de Ana AM, et al. 1997. Conformational changes required in the human growth hormone receptor for growth hormone signaling. J. Biol. Chem. 272:9189-96
94. 94. Merimee TJ. 1978. A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N. Engl. J. Med. 298:1217-22
95. 95. Merimee TJ, Fineberg SE, Hollander W. 1973. Vascular disease in the chronic HGH-deficient state. Diabetes 22:813-19
96. 96. Meyer DJ, Campbell GS, Cochran BH, Argetsinger LS, Larner AC, et al. 1994. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J. Biol. Chem. 269:4701-4
97. 97. Meyer DJ, Stephenson EW, Johnson L, Cochran BH, Schwartz J. 1993. The serum response element can mediate induction of c-fos by growth hormone. Proc. Natl. Acad. Sci. USA 90:6721-25
98. 98. Miller WL, Eberhardt NL. 1983. Structure and evolution of the growth hormone gene family. Endocr. Rev. 4:97-130
99. 99. Milman AE, Russell JA. 1950. Some aspects of purified pituitary growth hormone on carbohydrate metabolism in the rat. Endocrinology 47:114-19
100. 100. Moller C, Hansson A, Enberg B, Lobie PE, Norstedt G. 1992. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J. Biol. Chem. 267:23403-8
101. 101. Moller N, Moller J. Jorgensen JO, Ovesen P, Schmitz O, et al. 1993. Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin. Endocrinol. Oxford 39:577-81
102. 102. Naar EM, Bartke A, Majumdar SS, Buonomo FC, Yun JS, Wagner TE. 1991. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes. Biol. Reprod. 45:178-87
103. 103. Newman JD, Armstrong JM, Bornstein J. 1978. Effects of part sequences of human growth hormone on in vivo hepatic glycogen metabolism in the rat. Biochim. Biophys. Acta 544:234-44
104. 104. Niall HD, Hogan ML, Sauer R, Rosenblum IY, Greenwood FC. 1971. Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication. Proc. Natl. Acad. Sci. USA 68:866-70
105. 105. Nicoll CS, Mayer GL, Russell SM. 1986. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr. Rev. 7:169-203; Erratum. 1987. Endocr. Rev. 8:43
106. 105. Nicoll CS, Mayer GL, Russell SM. 1986. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocr. Rev. 7:169-203; Erratum. 1987. Endocr. Rev. 8:43
107. 106. Okada S, Kopchick JJ. 1996. Growth hormone inhibits translocation of protein kinase C-α and -γ stimulated by insulin in 3T3-F422A cells. Endocr. Soc. 78:275 (Abstr.)
108. 107. Orian JM, Lee CS, Weiss LM, Brandon MR. 1989. The expression of a metallothioncin-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver. Endocrinology 124:455-63
109. 108. Orian JM, Snibson K, Stevenson JL, Brandon MR, Herington AC. 1991. Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH. Endocrinology 128:1238-46
110. 109. Ornitz DM, Palmiter RD, Hammer RE, Brinster RL, Swift GH, MacDonald RJ. 1985. Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice. Nature 313:600-2
111. 110. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, et al. 1982. Dramatic growth of mice that develop from eggs microinjected with metallothioncin-growth hormone fusion genes. Nature 300:611-15
112. 111. Palmiter RD, Norstedt U, Gelinas RE, Hammer RE, Brinster RL. 1983. Metallothioncin-human GH fusion genes stimulate growth of mice. Science 222:809-14
113. 112. Pandian MR, Gupta SL, Talwar GP. 1971. Studies on the early interactions of growth hormone: effect in vitro on lipogenesis in adipose tissue. Endocrinology 88:928-36
114. 113. Porterfield SP. 1979. The effects of growth hormone, thyroxine and insulin on the activities of reduced nicotinamide adenine dinucleotide phosphate dehydrogenase, glucose-6-phosphatase and glycogen phosphorylase in fetal rat liver. Horm. Metab. Res. 11:444-48
115. 114. Press M. 1988. Growth hormone and metabolism. Diabetes Metab. Rev. 4:391-414
116. 115. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD. 1989. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124:40-48
117. 116. Ridderstrale M, Degerman E, Tornqvist H. 1995. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem. 270:3471-74
118. 117. Ridderstrale M, Tornqvist H. 1994. PI-3-kinase inhibitor Wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 203:306-10
119. 118. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, et al. 1993. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol. Cell Biol. 13:6260-73
120. 119. Rogers SA, Hammerman MR. 1989. Growth hormone activates phospholipase C in proximal tubular basolateral membranes from canine kidney. Proc. Natl. Acad. Sci. USA 86:6363-66
121. 120. Roos P, Fevold HR, Gemzell CA. 1965. Preparation of human growth hormone by gel filtration. Biochim. Biophys. Acta 74:525-31
122. 121. Rooyackers OE, Nair KS. 1997. Hormonal regulation of human muscle protein metabolism. Annu. Rev. Nutr. 17:457-85
123. 122. Roupas P, Herington AC. 1989. Cellular mechanisms in the processing of growth hormone and its receptor. Mol. Cell Endocrinol. 61:1-12
124. 123. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, et al. 1990. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med 323:1-6
125. 124. Russell J, Sherwood LM, Kowalski K, Schneider AB. 1981. Recombinant hormones from fragments of human growth hormone and human placental lactogen. J. Biol. Chem. 256:296-300
126. 125. Scanes CG, Campbell RM. 1995. Growth hormone: chemistry. In Growth Hormone, ed. S Harvey, CG Scanes, WH Daughaday, pp. 1-24. Boca Raton, FL: CRC
127. 126. Schindler C, Darnell JE Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-51
128. 127. Schwartz Y, Yamaguchi H, Goodman HM. 1992. Growth hormone increases intracellular free calcium in rat adipocytes: correlation with actions on carbohydrate metabolism. Endocrinology 131:772-78
129. 128. Deleted in Proof
130. 129. Shea BT, Hammer RE, Brinster RL. 1987. Growth allometry of the organs in giant transgenic mice. Endocrinology 121:1924-30
131. 130. Skaggs SR, Crist DM. 1991. Exogenous human growth hormone reduces body fat in obese women. Horm. Res. 35:19-24
132. 131. Slootweg MC, de Groot RP, Herrmann-Erlee MP, Koornncef I, Kruijer W, Kramer YM. 1991. Growth hormone induces expression of c-jun andjun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression. J. Mol. Endocrinol. 6:179-88
133. 132. Smal J, De Meyts P. 1987. Role of kinase C in the insulin-like effects of human growth hormone in rat adipocytes. Biochem. Biophys. Res. Commun. 147:1232-40
134. 133. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. 1996. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 10:519-33
135. 134. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, et al. 1997. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276: 1706-9
136. 135. Sonksen PH, Russell-Jones D, Jones RH. 1993. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm. Res. 40:68-79
137. 136. Sonksen PH, Salomon F, Cuneo R. 1991. Metabolic effects of hypopituitarism and acromegaly. Horm. Res. 36:27-31
138. 137. Sotiropoulos A, Moutoussamy S, Renaudie F, Clauss M, Kayser C, et al. 1996. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 10:998-1009
139. 138. Souza SC, Frick GP, Yip R, Lobo RB, Tai LR, Goodman HM. 1994. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 269:30085-88
140. 139. Strobl JS, Thomas MJ, 1994. Human growth hormone. Pharmacol. Rev. 46:1-34
141. 140. Swislocki NL. 1968. Effects of nutritional status and the pituitary on the acute plasma free fatty acid and glucose responses of rats to growth hormone administration. Metabolism 17:174-80
142. 141. Szabo M, Butz MR, Banerjee SA, Chikaraishi DM, Frohman LA. 1995. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5′-flanking sequences to the hypothalamus. Endocrinology 136:4044-48
143. 142. Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, et al. 1994. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J. Biol. Chem. 269:32358-67
144. 143. Turner ND, Knapp JR, Byers FM, Kopchick JJ. 1998. Expression of mutant bovine growth hormone genes in mice perturbs age-related nutrient utilization patterns. J. Nutr. 128:520-24
145. 144. Urich M, el Shemerly MY, Besser D, Nagamine Y, Ballmer-Hofer K. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-92
146. 145. Vance ML. 1992. Growth hormone therapy in adults. TIEM 3:46-48
147. 146. VanderKuur JA, Allevato G, Billestrup N, Norstedt G, Carter-Su C. 1995. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270:7587-93
148. 147. VanderKuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. 1997. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 138:4301-7
149. 148. VanderKuur JA, Wang X, Zhang L, Campbell GS, Allevato G, et al. 1994. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J. Biol. Chem. 269:21709-17
150. 149. Wang X, Darus CJ, Xu BC, Kopchick JJ. 1996. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Mol. Endocrinol. 10:1249-60
151. 150. Wang YD, Wood WI. 1995. Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. Mol. Endocrinol. 9:303-11
152. 151. Wanke R, Wolf E, Hermanns W, Folger S, Buchmuller T, Brem G. 1992. The GH-transgenic mouse as an experimental model for growth research: clinical and pathological studies. Horm. Res. 37:74-87
153. 152. Watahiki M, Yamamoto M, Yamakawa M, Tanaka M, Nakashima K. 1989. Conserved and unique amino acid residues in the domains of the growth hormones. Flounder growth hormone deduced from the cDNA sequence has the minimal size in the growth hormone prolactin gene family. J. Biol. Chem. 264:312-16
154. 153. Winston LA, Bertics PJ. 1992. Growth hormone stimulates the tyrosine phosphorylation of 42-and 45-kDa ERK-related proteins. J. Biol. Chem. 267:4747-51
155. 154. Winston LA, Hunter T. 1995. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270: 30837-40
156. 155. Wolf E, Kahnt E, Ehrlein J, Hermanns W, Brem G, Wanke R. 1993. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: lessons from transgenic animal models. Mech. Age. Dev. 68:71-87
157. 156. Wood TJ, Sliva D, Lobie PE, Pircher TJ, Gouilleux F, et al. 1995. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J. Biol. Chem. 270:9448-53
158. 157. Xu BC, Chen WY, Gu T, Ridgway D, Wiehl P, et al. 1995. Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation. J. Endocrinol. 146:131-39
159. 158. Xu BC, Wang X, Darus CJ, Kopchick JJ. 1996. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J. Biol. Chem. 271:19768-73
160. 159. Yang CW, Striker LJ, Kopchick JJ, Chen WY, Pesce CM, et al. 1993. Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene. Kidney Int. Suppl. 39:S90-94
161. 160. Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, et al. 1993. Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice. Lab. Invest. 68:62-70
162. 161. Yun JS, Li YS, Wight DC, Portanova R, Selden RF, Wagner TE. 1990. The human growth hormone transgene: expression in hemizygous and homozygous mice. Proc. Soc. Exp. Biol. Med. 194:308-13
163. 162. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, et al. 1997. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 94:13215-20